Studies have also suggested that podoplanin–CLEC-2-induced platelet activation promotes tumour growth (Miyata et al., 2017) and facilitates epithelial-to-mesenchymal transition (Takemoto et al., 2017). The gene discussed is PDPN; the disease is neoplasm.